Sulfonamides
Código 2935 (Harmonized System 2012 by 4 digits)
2023: US$39.6M, Total Trade Exchange
2023: US$931k, International Sales
2023: US$38.7M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Sulfonamides was US$39.6M.
In 2023, the states with the most international sales in Sulfonamides were Estado de México (US$868k) and Ciudad de México (US$25.8k).
The states with the most international purchases in 2023 were Ciudad de México (US$19.6M), Estado de México (US$9.59M), Jalisco (US$4.2M), Baja California (US$1.94M), and Nuevo León (US$1.1M).
In 2023, the main commercial destinations of Sulfonamides were Brazil (US$790k), India (US$80k), Colombia (US$9.55k), Argentina (US$7.9k), and Honduras (US$3.35k).
The main commercial origins of Sulfonamides in 2023 were Ireland (US$11.8M), India (US$11.6M), China (US$5.53M), United States (US$4.19M), and Spain (US$1.28M).
In the global context, the main exporting countries of Sulfonamides in 2022 were Ireland (US$3.18B), Switzerland (US$1.02B), and China (US$940M). In the same year, the main importing countries of Sulfonamides were United States (US$2.52B), Belgium (US$1.03B), and France (US$658M).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$39.6M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Sulfonamides in Mexico (including international purchases and sales) was US$39.6M.
The visualizations show the net balance of Sulfonamides at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionJuly, 2024
- US$6.33M, International Purchases
- US$31.7k, International Sales
In July 2024, international sales of Sulfonamides were US$31.7k, while international purchases reached US$6.33M. The above results in a trade balance of -US$6.3M.
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionEstado de México: US$868k, State with the Most International Sales (2023)
Brazil: US$790k, Main commercial destination (2023)
In 2023, the states with the highest international sales in Sulfonamides were Estado de México (US$868k) and Ciudad de México (US$25.8k).
In 2023, the countries with the most international purchases from Mexico were Brazil (US$790k), India (US$80k), Colombia (US$9.55k), Argentina (US$7.9k), and Honduras (US$3.35k).
International Purchases
#permalink to sectionCiudad de México: US$19.6M, State with the Most International Purchases (2023)
Ireland: US$11.8M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Sulfonamides were Ciudad de México (US$19.6M), Estado de México (US$9.59M), Jalisco (US$4.2M), Baja California (US$1.94M), and Nuevo León (US$1.1M).
The countries with the most international sales to Mexico in 2023 were Ireland (US$11.8M), India (US$11.6M), China (US$5.53M), United States (US$4.19M), and Spain (US$1.28M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Sulfonamides and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Sulfonamides. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.019%, Mexican share in global exports - 2022
- 0.59%, Mexican share in global imports - 2022
The visualizations show the global market for Sulfonamides. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Sulfonamides were Ireland (US$3.18B), Switzerland (US$1.02B), and China (US$940M). In the same year, the main importing countries for Sulfonamides were United States (US$2.52B), Belgium (US$1.03B), and France (US$658M).